1. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for
biotechnology. Trends Biotechnol. 2006;24(4):150–154. doi: 10.1016/j.tibtech.2006.01.010.
2. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult
marrow. Nature. 2002;418(6893):41–49. doi: 10.1038/nature00870.
3. Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function
in a rat model of dilated cardiomyopathy. Circulation. 2005;112(8):1128–1135. doi: 10.1161/CIRCULATIO
NAHA.104.500447.
4. Safford KM, Hicok KC, Safford SD, et al. Neurogenic differentiation of murine and human adipose-derived
stromal cells. Biochem Biophys Res Commun. 2002;294(2):371–379. doi: 10.1016/S0006-291X(02)00469-2.
5. Yamamoto T, Gotoh M, Kato M, et al. Periurethral injection of autologous adipose-derived regenerative
cells for the treatment of male stress urinary incontinence: report of three initial cases. Int J Urol.
2012;19(7):652–659. doi: 10.1111/j.1442-2042.2012.02999.x.
6. Gotoh M, Yamamoto T, Kato M, et al. Regenerative treatment of male stress urinary incontinence by
periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Int
J Urol. 2014;21(3):294–300. doi: 10.1111/iju.12266.
7. Gotoh M, Yamamoto T, Shimizu S, et al. Treatment of male stress urinary incontinence using autologous
adipose-derived regenerative cells: long-term efficacy and safety. Int J Urol. 2019;26(3):400–405. doi:
10.1111/iju.13886.
8. Shimizu S, Yamamoto T, Nakayama S, et al. Design of a single-arm clinical trial of regenerative therapy
by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence in Japan:
the ADRESU study protocol. BMC Urol. 2017;17(1):89. doi: 10.1186/s12894-017-0282-7.
9. Gleave M, Tolcher A, Miyake H, et al. Progression to androgen independence is delayed by adjuvant
treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
Clin Cancer Res. 1999;5(10):2891–2898.
10. Xu Q, Wang L, Li H, et al. Mesenchymal stem cells play a potential role in regulating the establishment
and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and
induced autocrine TGF-b. Int J Oncol. 2012;41(3):959–968. doi: 10.3892/ijo.2012.1541.
11. Sakurai M, Miki Y, Takagi K, et al. Interaction with adipocyte stromal cells induces breast cancer malignancy
via S100A7 upregulation in breast cancer microenvironment. Breast Cancer Res. 2017;19(1):70. doi: 10.1186/
s13058-017-0863-0.
12. Li Y, Xu X, Wang L, et al. Senescent mesenchymal stem cells promote colorectal cancer cells growth via
galectin-3 expression. Cell Biosci. 2015;5:21. doi: 10.1186/s13578-015-0012-3.
13. Cousin B, Ravet E, Poglio S, et al. Adult stromal cells derived from human adipose tissue provoke pancreatic
cancer cell death both in vitro and in vivo. PLoS One. 2009;4(7):e6278. doi: 10.1371/journal.pone.0006278.
14. Prantl L, Muehlberg F, Navone NM, et al. Adipose tissue-derived stem cells promote prostate tumor growth.
Prostate. 2010;70(15):1709–1715. doi: 10.1002/pros.21206.
15. Takahara K, Ii M, Inamoto T, et al. Adipose-derived stromal cells inhibit prostate cancer cell proliferation
inducing apoptosis. Biochem Biophys Res Commun. 2014;446(4):1102–1107. doi: 10.1016/j.bbrc.2014.03.080.
16. Takahara K, Ii M, Inamoto T, et al. microRNA-145 mediates the inhibitory effect of adipose tissue-derived
stromal cells on prostate cancer. Stem Cells Dev. 2016;25(17):1290–1298. doi: 10.1089/scd.2016.0093.
...